Cheng Hsi-Tsung, Yu Hui-Yuan, Gordon John R, Li Fang, Cheng Jya-Wei
Institute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu 300, Taiwan.
Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5B4, Canada.
Molecules. 2017 Jul 21;22(7):1229. doi: 10.3390/molecules22071229.
The ELR-CXC chemokines are important to neutrophil inflammation in many acute and chronic diseases. Among them, CXCL8 (interleukin-8, IL-8), the expression levels of which are elevated in many inflammatory diseases, binds to both the CXCR1 and CXCR2 receptors with high affinity. Recently, an analogue of human CXCL8, CXCL8K11R/G31P (hG31P) has been developed. It has been demonstrated that hG31P is a high affinity antagonist for both the CXCR1 and CXCR2. Herein, we have determined the solution structure and the CXCR1 N-terminal peptide binding sites of hG31P by NMR spectroscopy. We have found that the displacement within the tertiary structure of the 30 s loop and the N-terminal region and more specifically change of the loop conformation (especially H33), of hG31P may affect its binding to the CXCR1 receptor and thereby inhibit human neutrophil chemotactic responses induced by ELR-CXC chemokines. Our results provide a structural basis for future clinical investigations of this CXCR1/CXCR2 receptor antagonist and for the further development of CXCL8 based antagonists.
ELR-CXC趋化因子在许多急性和慢性疾病的中性粒细胞炎症中起着重要作用。其中,CXCL8(白细胞介素-8,IL-8)在许多炎症性疾病中表达水平升高,它以高亲和力与CXCR1和CXCR2受体结合。最近,一种人CXCL8类似物CXCL8K11R/G31P(hG31P)已被研发出来。已证明hG31P是CXCR1和CXCR2的高亲和力拮抗剂。在此,我们通过核磁共振光谱法确定了hG31P的溶液结构和CXCR1 N端肽结合位点。我们发现,hG31P的30 s环和N端区域三级结构内的位移,更具体地说是环构象(特别是H33)的变化,可能会影响其与CXCR1受体的结合,从而抑制ELR-CXC趋化因子诱导的人中性粒细胞趋化反应。我们的结果为该CXCR1/CXCR2受体拮抗剂未来的临床研究以及基于CXCL8的拮抗剂的进一步开发提供了结构基础。